MedPath

Effect of 25-OH-vitamin D3 on the Liver Transplant Recipients

Completed
Conditions
Liver Transplant Disorder
Registration Number
NCT04111146
Lead Sponsor
Asan Medical Center
Brief Summary

The low vitamin D3 levels and malnutrition before liver transplantation showed an increase in the length of stay in ICU and hospital. Although several factors may influence the clinical outcomes of patients with liver transplantation, low vitamin D3 levels showed an independent risk factor. It is necessary to prospectively analyze the effect of vitamin D supplements on clinical outcomes in liver transplant recipients.

Detailed Description

Purpose: Vitamin D deficiency is common in patients of chronic liver disease and has been associated with infection and mortality. The aim of this study is to determine whether preoperative vitamin D levels affect clinical outcomes after liver transplantation.

Methods : This was a single-center retrospective study. Between June and November 2017, a total of 219 patients underwent liver transplantation. The primary outcome was the relationship between serum 25-OH-vitamin D3 level before liver transplantation and length of stay in the intensive care unit (ICU). Secondary outcomes included the duration of normalization of inflammatory marker, such as white blood cell count (WBC) \& C-reactive protein (CRP) after liver transplantation, new infection rates, rejection rates, the length of hospital stay and mortality among vitamin D level.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
219
Inclusion Criteria
  • The patients who admitted to intensive care unit (ICU) after liver transplantation were studied
Read More
Exclusion Criteria
  • Patients who didn't have preoperative vitamin D level
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hospital stay after liver transplant6 months

compared with each group

Secondary Outcome Measures
NameTimeMethod
Length of ICU stay6 months

compared with each group

duration of normalization of CRP, WBC6 months

compared with each group

New infection rate6 months

compared with each group

Trial Locations

Locations (1)

Hakjae Lee

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath